l carnitine tmao conversion γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to Frontiers | The microbial metabolite
Frontiers The microbial metabolite trimethylamine N oxide and the kidney diseases The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect Optimal DX FYI: Gut Microbes Increase TMAO Gutheart axis: emerging therapies targeting trimethylamine N oxide production PMC
Pay in 4 interest-free payments of $7.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20



